Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation
- 27 June 2011
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 32 (8) , 1045-1054
- https://doi.org/10.1038/aps.2011.67
Abstract
Aim: Methods: Results: Conclusion:Keywords
This publication has 39 references indexed in Scilit:
- Gene–environment interactions in asthma and allergy: the end of the beginning?Current Opinion in Allergy and Clinical Immunology, 2010
- Cooperative Interactions between TLR4 and TLR9 Regulate Interleukin 23 and 17 Production in a Murine Model of Gram Negative Bacterial PneumoniaPLOS ONE, 2010
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular FillingNew England Journal of Medicine, 2010
- Linking oxidative stress to inflammation: Toll-like receptorsPublished by Elsevier ,2010
- Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- The role of Toll-like receptor-4 in pertussis vaccine-induced immunityBMC Immunology, 2008
- Molecular pathogenesis of emphysemaJournal of Clinical Investigation, 2008
- The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune diseaseClinical and Experimental Immunology, 2007
- Toll-like receptor 4 deficiency causes pulmonary emphysemaJournal of Clinical Investigation, 2006